Version 2.0 of the Draft CRI Guidelines 2025 introduces updated examination procedures for AI, blockchain, and quantum-based inventions, and includes an extensive annexure of examples clarifying Section 3(k) exclusions.
Read more about Indian Patent Office Issues Draft CRI Guidelines 2025 – Version 2.0: Key Additions and ChangesTag: Patent Law india
ITC’s Nicotine Device Patent Rejection on Public Health Grounds Set Aside
The Calcutta High Court has set aside the refusal of ITC’s patent application for a nicotine aerosol device. The Court found that the Controller’s reliance on morality grounds under Section 3(b) was improper and unsupported by cited documents, ensuring a fresh review of the patent.
Read more about ITC’s Nicotine Device Patent Rejection on Public Health Grounds Set AsidePatent for Enzyme-Based Animal Feed Supplementation Cleared of Section 3(i) Refusal
The Madras High Court has allowed Kemin Industries’ patent on an enzyme-based animal feed method, overturning the Controller’s Section 3(i) refusal. The Court ruled that the method involves feed supplementation rather than treatment, confirming novelty and inventive step in the process.
Read more about Patent for Enzyme-Based Animal Feed Supplementation Cleared of Section 3(i) RefusalAnti-Cancer Patent Refusal Set Aside for Not Identifying ‘Known Substance’
In a recent ruling, the Delhi High Court overturned the rejection of an anti-cancer patent filed by Taiho Pharmaceutical. The Court highlighted that objections under Section 3(d) must explicitly state the “known substance” being referenced and directed a fresh hearing for proper assessment.
Read more about Anti-Cancer Patent Refusal Set Aside for Not Identifying ‘Known Substance’Indian IP Office Announces Stakeholder Meetings on Draft CRI Guidelines
The Indian IP Office has scheduled in-person stakeholder meetings in Mumbai and Delhi to gather feedback on the Draft Guidelines for Computer Related Inventions (CRI). The initiative will allow stakeholders to share their inputs before the finalisation of the CRI policy framework.
Read more about Indian IP Office Announces Stakeholder Meetings on Draft CRI GuidelinesWhat Have You Been Smoking? Personal bias has no place in Tobacco patent evaluation
The Calcutta High Court has criticised the arbitrary rejection of a tobacco syrup patent by the Indian patent office, urging objective analysis over personal bias. It held that Section 3(b) must not be misused to deny legitimate inventions without proper legal scrutiny and evidence.
Read more about What Have You Been Smoking? Personal bias has no place in Tobacco patent evaluationPatent Rejection for Vehicle Monitoring System reversed by Court
The Madras High Court allowed the appeal filed by TVS Motor Company against the rejection of its patent application pertaining to a Vehicle Monitoring System. The Court observed that the Controller had not adequately examined the validity of the cited prior art and had failed to provide a reasoned analysis with respect to the inventive step. Consequently, the matter was remanded to a different Controller for fresh consideration.
Read more about Patent Rejection for Vehicle Monitoring System reversed by CourtRisdiplam – Spinal Muscular Atrophy Case: Delhi HC Favors Public Health Over Roche Patent
The Delhi High Court, in a significant ruling dated March 24th, 2024, rejected the interim injunction application of F Hoffmann-La Roche AG (“Roche”) against Natco...
Read more about Risdiplam – Spinal Muscular Atrophy Case: Delhi HC Favors Public Health Over Roche PatentMadras HC Overrules Procedural Rejection in France Telecom’s Patent Case
The Madras High Court allowed France Telecom’s writ petition, setting aside the procedural rejection of its patent application examination request. The judgment clarifies the treatment of agent errors under Indian patent law and upholds procedural fairness.
Read more about Madras HC Overrules Procedural Rejection in France Telecom’s Patent CaseMadras High Court Upholds Patent Validity in Embio Limited vs. Malladi Drugs & Pharmaceuticals
The Madras High Court affirmed the validity of Malladi Drugs’ patent for chiral beta-amino alcohols, highlighting the invention’s novelty and inventive step. The judgment clarifies key principles on patent revocation and the definition of a “person interested” under Indian patent law.
Read more about Madras High Court Upholds Patent Validity in Embio Limited vs. Malladi Drugs & Pharmaceuticals